Stemcell Holdings Inc (STMM)
OTHER OTC:STMM
US Market
Holding STMM?
Track your performance easily

Stemcell Holdings (STMM) Stock Price & Analysis

4 Followers

STMM Stock Chart & Stats


Financials

Annual

Risk Analysis

Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy

Website Traffic

Sorry, No Data Available
There is no website visitor data available for this stock.
---

STMM FAQ

What was Stemcell Holdings Inc’s price range in the past 12 months?
Stemcell Holdings Inc lowest stock price was $0.08 and its highest was $0.75 in the past 12 months.
    What is Stemcell Holdings Inc’s market cap?
    Currently, no data Available
    When is Stemcell Holdings Inc’s upcoming earnings report date?
    The company’s upcoming earnings report date is not yet available.
    How were Stemcell Holdings Inc’s earnings last quarter?
    Currently, no data Available
    Is Stemcell Holdings Inc overvalued?
    According to Wall Street analysts Stemcell Holdings Inc’s price is currently same. Get more investment ideas with TipRanks Premium
      Does Stemcell Holdings Inc pay dividends?
      Stemcell Holdings Inc does not currently pay dividends.
      What is Stemcell Holdings Inc’s EPS estimate?
      Stemcell Holdings Inc’s EPS estimate for its next earnings report is not yet available.
      How many shares outstanding does Stemcell Holdings Inc have?
      Stemcell Holdings Inc has 427,378,000 shares outstanding.
        What happened to Stemcell Holdings Inc’s price movement after its last earnings report?
        Currently, no data Available
        Which hedge fund is a major shareholder of Stemcell Holdings Inc?
        Currently, no hedge funds are holding shares in STMM
        ---

        Stemcell Holdings Stock Smart Score

        Company Description

        Stemcell Holdings Inc

        Stemcell Holdings, Inc. is a holding company, which through its subsidiary, Stemcell Co., Ltd., is engaged in the regenerative medicine-related business. It provides two different options for stem cell regenerative therapy: Autologous Adipose derived Mesenchymal stem cells and Natural killer cells. The company was founded on December 31, 2015 and is headquartered in Tokyo, Japan.
        ---
        Similar Stocks
        Company
        Price & Change
        Follow
        Accelerate Diagnostics
        Castle Biosciences
        Fulgent Genetics
        10x Genomics
        Popular Stocks
        ---
        What am I Missing?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis